HHS Secretary Alex Azar The Department of Health and Human Services is proposing to lower the list price of prescription drugs by correcting what it calls the perverse incentive to increase list prices to get higher rebates. The rebates are passed on to health plans, which use them to lower the price of premiums. But… Read More »
A federal court has sided with the American Hospital Association and others in ruling that the Department of Health and Human Services unlawfully cut payment rates for certain outpatient drugs. HHS Secretary Alex Azar exceeded his legal authority in setting new reimbursement rates in the outpatient prospective payment system rule for 2018, United States District… Read More »
(Reuters Health) – – Isotretinoin, a drug for severe chronic acne, has long been linked to miscarriages, birth defects and other serious problems, but a research review suggests much of data on the drug’s safety, effectiveness and side effects may be unreliable. The analysis in the Cochrane Database of Systematic Reviews concludes that the available… Read More »